Fahad Alsaikhan

2.1k total citations
103 papers, 1.5k citations indexed

About

Fahad Alsaikhan is a scholar working on Molecular Biology, Cancer Research and Biomaterials. According to data from OpenAlex, Fahad Alsaikhan has authored 103 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 22 papers in Cancer Research and 14 papers in Biomaterials. Recurrent topics in Fahad Alsaikhan's work include MicroRNA in disease regulation (18 papers), Circular RNAs in diseases (15 papers) and Cancer-related molecular mechanisms research (11 papers). Fahad Alsaikhan is often cited by papers focused on MicroRNA in disease regulation (18 papers), Circular RNAs in diseases (15 papers) and Cancer-related molecular mechanisms research (11 papers). Fahad Alsaikhan collaborates with scholars based in Saudi Arabia, Iraq and Iran. Fahad Alsaikhan's co-authors include Abduladheem Turki Jalil, Bagher Farhood, Andrés Alexis Ramírez‐Coronel, Moaed E. Al‐Gazally, Pushpamala Ramaiah, Maria Jade Catalan Opulencia, Jitendra Gupta, Mustafa M. Kadhim, Jahidur Rashid and Fakhrul Ahsan and has published in prestigious journals such as PLoS ONE, Molecules and International Journal of Pharmaceutics.

In The Last Decade

Fahad Alsaikhan

100 papers receiving 1.4k citations

Peers

Fahad Alsaikhan
Hamid A. Bakshi United Kingdom
Hashem O. Alsaab Saudi Arabia
Di Huang China
Jin Woo Park South Korea
Xue Wang China
Fahad Alsaikhan
Citations per year, relative to Fahad Alsaikhan Fahad Alsaikhan (= 1×) peers Yuxuan Zhu

Countries citing papers authored by Fahad Alsaikhan

Since Specialization
Citations

This map shows the geographic impact of Fahad Alsaikhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fahad Alsaikhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fahad Alsaikhan more than expected).

Fields of papers citing papers by Fahad Alsaikhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fahad Alsaikhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fahad Alsaikhan. The network helps show where Fahad Alsaikhan may publish in the future.

Co-authorship network of co-authors of Fahad Alsaikhan

This figure shows the co-authorship network connecting the top 25 collaborators of Fahad Alsaikhan. A scholar is included among the top collaborators of Fahad Alsaikhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fahad Alsaikhan. Fahad Alsaikhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saadh, Mohamed J., Hanan Hassan Ahmed, Mohammed Ahmed Mustafa, et al.. (2024). Small molecule and big function: MicroRNA-mediated apoptosis in rheumatoid arthritis. Pathology - Research and Practice. 261. 155508–155508. 1 indexed citations
2.
Аlmajidi, Yasir Q., Sivasankaran Ponnusankar, MVNL Chaitanya, et al.. (2024). Chitosan-based nanofibrous scaffolds for biomedical and pharmaceutical applications: A comprehensive review. International Journal of Biological Macromolecules. 264(Pt 2). 130683–130683. 39 indexed citations
3.
Saadh, Mohamed J., Chou‐Yi Hsu, Mohammed Ahmed Mustafa, et al.. (2024). Advances in chitosan-based blends as potential drug delivery systems: A review. International Journal of Biological Macromolecules. 273(Pt 1). 132916–132916. 29 indexed citations
4.
Saadh, Mohamed J., et al.. (2024). MicroRNAs Modulating Neuroinflammation in Parkinson's disease. Inflammation. 48(3). 1042–1062. 5 indexed citations
5.
Hsu, Chou‐Yi, Omer Qutaiba B. Allela, Ali M. Hussein, et al.. (2024). Recent advances in polysaccharide-based drug delivery systems for cancer therapy: a comprehensive review. Artificial Cells Nanomedicine and Biotechnology. 52(1). 564–586. 17 indexed citations
6.
Alsaikhan, Fahad & Bagher Farhood. (2024). Recent advances on chitosan/hyaluronic acid-based stimuli-responsive hydrogels and composites for cancer treatment: A comprehensive review. International Journal of Biological Macromolecules. 280(Pt 3). 135893–135893. 18 indexed citations
7.
Saadh, Mohamed J., et al.. (2024). Association of polyomavirus infection with lung cancer: A systematic review and meta-analysis. Pathology - Research and Practice. 262. 155521–155521.
8.
Jalil, Abduladheem Turki, Fahad Alsaikhan, Mohaned Adil, et al.. (2023). DFT, molecular docking, and ADMET studies for the adsorption behavior and anti-inflammatory activity of thiazole by B12N12 and OH-B12N12 nanoclusters. Diamond and Related Materials. 136. 110044–110044. 7 indexed citations
9.
Zhang, Xin, Tariq J. Al‐Musawi, Fahad Alsaikhan, et al.. (2023). Effect of loading of Pt-decorated TiO2 on the enhancement of aerobic photo-oxidation of benzyl alcohol. Molecular Catalysis. 547. 113247–113247. 9 indexed citations
10.
Gupta, Jitendra, Waleed K. Abdulsahib, Abduladheem Turki Jalil, et al.. (2023). Prostate cancer and microRNAs: New insights into apoptosis. Pathology - Research and Practice. 245. 154436–154436. 9 indexed citations
11.
Zabibah, Rahman S., Mohamed J. Saadh, Fahad Alsaikhan, et al.. (2023). Role of microRNA-146a in cancer development by regulating apoptosis. Pathology - Research and Practice. 254. 155050–155050. 8 indexed citations
12.
Almajidi, Yasir Qasim, Mustafa M. Kadhim, Fahad Alsaikhan, et al.. (2023). Doxorubicin-loaded micelles in tumor cell-specific chemotherapy. Environmental Research. 227. 115722–115722. 48 indexed citations
13.
Gupta, Jitendra, Abduladheem Turki Jalil, Zafar Aminov, et al.. (2023). The Radiosensitizing Potentials of Silymarin/Silibinin in Cancer: A Systematic Review. Current Medicinal Chemistry. 31(42). 6992–7014. 2 indexed citations
14.
Alkhathami, Ali G., et al.. (2023). Hydrogel assistant synthesis of new Ti-MOF cross-linked oxidized pectin and chitosan with anti-breast cancer properties. Frontiers in Materials. 10. 10 indexed citations
15.
Al‐Awsi, Ghaidaa Raheem Lateef, Fahad Alsaikhan, Ria Margiana, et al.. (2023). Shining the light on mesenchymal stem cell-derived exosomes in breast cancer. Stem Cell Research & Therapy. 14(1). 21–21. 11 indexed citations
16.
Alsaikhan, Fahad, Rasha Fadhel Obaid, Shohreh Jahani, et al.. (2023). Development of the DNA-based voltammetric biosensor for detection of vincristine as anticancer drug. Frontiers in Chemistry. 10. 1060706–1060706. 8 indexed citations
17.
Al‐Haideri, Maysoon, Samaneh Rostami, Abduladheem Turki Jalil, et al.. (2022). CAR-T cell combination therapy: the next revolution in cancer treatment. Cancer Cell International. 22(1). 365–365. 104 indexed citations
18.
Iqbal, Muhammad Shahid, Muhammad Zahid Iqbal, Yaman Walid Kassab, et al.. (2020). Determinants of health-related quality of life among warfarin patients in Pakistan. PLoS ONE. 15(6). e0234734–e0234734. 8 indexed citations
19.
Iqbal, Muhammad Zahid, et al.. (2020). Knowledge, Attitude, and Practice of Oral Hygiene Among Students of a Private University. Journal of Pharmacy And Bioallied Sciences. 13(1). 123–128. 5 indexed citations
20.
Chaudhry, Imtiaz A., Fahad Alsaikhan, Waleed Al-Rashed, et al.. (2014). Intralesional OK-432 (Picibanil) Sclerosing Agent in the Treatment of Orbital Lymphangiomas. Investigative Ophthalmology & Visual Science. 55(13). 4081–4081. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026